VWR:NGS-VWR Corporation

EQUITY | Medical Devices | Nasdaq Global Select

Last Closing

USD 33.25

Change

0.00 (0.00)%

Market Cap

USD 3.46B

Volume

2.80M

Analyst Target

USD 32.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

VWR Corp is a provider of laboratory products, services and solutions to the life science, general research and applied markets. It also provides value-added services such as custom manufacturing.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

-0.45 (-0.32%)

USD 51.34B
ALGN Align Technology Inc

+7.96 (+2.49%)

USD 24.03B
BRKR Bruker Corporation

+1.46 (+1.58%)

USD 12.93B
PODD Insulet Corporation

+3.66 (+2.21%)

USD 11.49B
SWAV Shockwave Medical Inc

+6.54 (+2.07%)

USD 10.25B
MASI Masimo Corporation

+3.83 (+2.72%)

USD 7.14B
AXNX Axonics Modulation Technologie..

-0.06 (-0.09%)

USD 3.52B
IRTC iRhythm Technologies Inc

+0.76 (+0.66%)

USD 3.36B
QDEL Quidel Corporation

+1.26 (+2.68%)

USD 3.14B
LIVN LivaNova PLC

+1.48 (+2.72%)

USD 3.02B

ETFs Containing VWR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.44% N/A N/A N/A N/A
Dividend Return 7.44% N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.89% N/A N/A N/A N/A
Risk Adjusted Return 75.16% N/A N/A N/A N/A
Market Capitalization 3.46B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 19.90 N/A N/A
Price/Book Ratio 12.98 N/A N/A
Price / Cash Flow Ratio 15.60 N/A N/A
Price/Free Cash Flow Ratio -80.70 N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.